Shannon Stapleton | Reuters
The drugstore chain reported fiscal fourth-quarter net income of $975 million, or 75 cents per share, down from $1.74 billion, or $1.33 per share, a year earlier. Revenue rose to $69.55 billion, from $66.89 billion a year prior. That's higher than analysts' expectations of $68.75 billion, according to Refinitiv.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
CV, covid ? upload them on linkedin, it's a Microsoff company
$CLOV LFG.
$CLOV LfG